HomeCRVS • NASDAQ
add
Corvus Pharmaceuticals Inc
Previous close
$15.72
Day range
$15.57 - $15.94
Year range
$2.54 - $26.95
Market cap
1.31B USD
Avg Volume
1.31M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.22M | 50.73% |
Net income | -12.32M | -1.72% |
Net profit margin | — | — |
Earnings per share | -0.15 | -4.97% |
EBITDA | -12.19M | -50.79% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 56.75M | 9.21% |
Total assets | 71.12M | 3.21% |
Total liabilities | 9.91M | -72.72% |
Total equity | 61.20M | — |
Shares outstanding | 83.99M | — |
Price to book | 19.17 | — |
Return on assets | -40.30% | — |
Return on capital | -45.27% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -12.32M | -1.72% |
Cash from operations | -9.19M | -8.58% |
Cash from investing | 10.88M | 278.86% |
Cash from financing | 20.00K | -99.89% |
Net change in cash | 1.71M | -57.91% |
Free cash flow | -4.99M | 69.29% |
About
Founded
2014
Headquarters
Website
Employees
37
